Expert Perspectives on Clinical Laboratory Accreditation for Polygenic Risk Scores
Wallingford, C. K.; Clinch, T.; Fowles, L.; Young, M.-A.; Leo, P.; Shah, S.; McInerney-Leo, A.; Bell, K.; Saya, S.; Siggs, O.; Spaeth, E.; Souzeau, E.; Inouye, M.; Marum, J.; MacGregor, S.; Busby, G. B.; James, P.; Yanes, T.
Show abstract
BackgroundPolygenic risk scores (PRS) are rapidly being translated into clinical practice to estimate risk to health conditions and inform health management. However, the lack of clear guidelines for laboratory accreditation of PRS restricts the ability of researchers, clinicians and regulatory bodies to evaluate test quality. Via stakeholder consultation, this study aimed to describe the unique aspects of PRS laboratory accreditation to inform test assessments by providers. MethodsEligible individuals were stakeholders involved in ordering, performing, reporting, and accrediting PRS in Australia. Semi-structured interviews explored the unique challenges and considerations of PRS testing. Interviews were transcribed verbatim, and deductive content analysis conducted. ResultsParticipants were genetic clinicians, laboratory scientists, researchers, and industry experts with experience in PRS laboratory accreditation (n=13). Four topic areas were developed covering the entire PSR testing pipeline: i) laboratory methods, ii) PRS algorithm, iii) clinical context, and iv) reporting results. Stakeholders identified well-established laboratory methods for sample collection, genotyping and quality controls, which are applicable to PRS. Use of imputation was identified as a unique consideration for test accreditation, which impacts transparency and quality assessments of the final PRS calculation. Ancestry considerations were a major theme, impacting on all aspects of PRS pipeline. It was also widely agreed that PRS algorithms would need to be regularly identified that this process aligned with existing accreditation body allowances for test improvements. Additional considerations included the need to develop quality standards for the management of missing data, defined validation processes, and processes for collecting additional risk factors if delivering integrated risk. Finally, the importance of clear reporting of risk assessment was explored. ConclusionsThe findings highlight the unique considerations for PRS accreditation and can inform the development of technical standards in Australian and international diagnostic laboratories. Furthermore, a series of checklists was developed based on findings to aid providers and accreditation bodies alike assessing PRS testing.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change 94%
- Distinct rates of VUS reclassification are observed when subclassifying VUS by evidence level 93%
- Development and evaluation of a novel educational program for providers on the use of polygenic risk scores 92%
Similar papers in this journal
- Variant Scientists in Genomic Medicine: Survey of Demographics, Training, Duties, and Professional Development 94%
- Clinical Validation and Diagnostic Utility of Optical Genome Mapping in Prenatal Diagnostic Testing 91%
- Production and performance assessment of a SARS-CoV-2 biomimetic in a verification program for pandemic readiness 90%
Similar papers in this journal
- Evaluation of SARS-CoV-2 Antibody Point of Care Devices in the Laboratory and Clinical Setting 92%
- Feedback of Individual Genetic and Genomics Research Results: A Qualitative Study Involving Grassroots Communities in Uganda 91%
- Evaluation of the accuracy and ease-of-use of Abbott PanBio - A WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2 90%
Similar papers in this journal
- A Pooled Electronic Consultation Program to Improve Access to Genetics Specialists 91%
- A clinical algorithm to identify people with the glucose-6-phosphate dehydrogenase p.Val68Met variant at risk for diabetes undertreatment 88%
- Early Diagnosis of Vascular Ehlers-Danlos Syndrome Through AI-Powered Facial Analysis: Results from the Montalcino Aortic Consortium 87%
Similar papers in this journal
- Clinical genetics lacks standard definitions and protocols for the collection and use of diversity measures 93%
- Validating data from Multiplex Assays of Variant Effect (MAVEs): A CanVIG-UK National Survey of NHS Clinical Scientists 91%
- Returning Actionable Genomic Results in a Research Biobank: Analytic Validity, Clinical Implementation and Resource Utilization 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.